GROWTH BUYOUT & VENTURE CAPITAL

Engaged Partnership - A long-term view.
The essentials for transformative growth in life sciences.

 


Latest Investment

Innocoll is a global, commercial stage specialty pharmaceutical and medical device company with late stage development programs targeting areas of significant

News

2017-08-30

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors